Table 1.
Patient characteristics
| Study Group | Total | ||||
| 70 to 75 years | > 75 years | ||||
| 80 mg/m2 (n = 15) | 90 mg/m2 (n = 14) | 60 mg/m2 (n = 7) | 70 mg/m2 (n = 8) | (n = 44) | |
| Median age (range, in years) | 73 (71 to 74) | 73 (71 to 74) | 79 (76 to 84) | 77 (76 to 85) | 74 (71 to 75) |
| Gender | |||||
| Male | 12 | 12 | 5 | 5 | 34 (77%) |
| Female | 3 | 2 | 2 | 3 | 10 (23%) |
| Karnofsky performance status | |||||
| 70 | 8 | 7 | 4 | 3 | 22 (50%) |
| 80 – 90 | 7 | 7 | 3 | 5 | 22 (50%) |
| Stage: | |||||
| IIIA | 5 | 1 | - | 2 | 8 (18%) |
| IIIB | 5 | 8 | 3 | 1 | 17 (39%) |
| IV | 5 | 5 | 4 | 5 | 19 (43%) |
| Histology: | |||||
| Squamous cell carcinoma | 9 | 5 | 2 | 7 | 23 (52%) |
| Adenocarcinoma | 3 | 7 | 3 | - | 13 (30%) |
| Others | 3 | 2 | 2 | 1 | 8 (18%) |